Sensitizers and protectors of radiation and chemotherapy.
Poggi
M M
MM
Radiation Oncology Sciences Program, National Cancer Institute, Bethesda, Maryland, USA.
Coleman
C N
CN
Mitchell
J B
JB
D004999:Amifostine / Q000494:pharmacology; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D011465:Prostaglandins, Synthetic / Q000494:pharmacology; D011829:Radiation Dosage; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D012680:Sensitivity and Specificity
D011465:Prostaglandins, Synthetic; D011838:Radiation-Sensitizing Agents; D004999:Amifostine